Child & Adolescent Behavioral Problems
Disruptive, Impulse-Control, and Conduct Disorders (DSM-5-TR)
Oppositional behavior, aggression, conduct problems, and emotional dysregulation in youth. Includes ODD, conduct disorder, and ADHD-related behavioral challenges. Parent training approaches (PCIT, Triple P) and family therapies (FFT, MST) have strong evidence.
Prevalence: ~3.3% for ODD and ~4% (median) for conduct disorder per DSM-5-TR; community estimates for ODD mostly fall between 3% and 6%
Clinical Picture
Child therapy is a fundamentally different enterprise than adult therapy. Children communicate through play, behavior, and the body more than through words. The 'client' is almost always the family system, even when the child is the identified patient. Behavioral problems in children are frequently signals of environmental stress, developmental disruption, or trauma rather than intrinsic pathology. The evidence base is weighted toward parent-focused and family-based interventions because changing the child's relational environment is often more powerful than changing the child directly.
Treatment Considerations
Parent-Child Interaction Therapy (PCIT) and Parent Management Training have strong evidence for disruptive behavior disorders. Play Therapy (both directive and non-directive) provides developmentally appropriate access to the child's inner world. Theraplay addresses attachment through structured play interactions. TF-CBT is the gold standard for child trauma. For all child presentations, assessment of the family system, school environment, and developmental history is essential before selecting a modality. The younger the child, the more the treatment should center on the caregiving relationship rather than the child alone.
20 Therapeutic Approaches
Sorted by evidence tier: guideline-recommended first, then RCT-supported, then emerging/limited evidence.
Related Clinical Vignettes
Sources & References
Prevalence data from NIMH, WHO, and DSM-5-TR field trial publications. Evidence tiers reflect guideline status (APA, NICE, VA/DoD, WHO) and meta-analytic findings as of early 2025. Individual modality citations are listed on each modality page. Full bibliography available on the Sources page.